# Milestone Pharmaceuticals Inc. (MIST)

> Healthcare · CA · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/MIST/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 797.0K | $ -54.68M | $ -38.61M | $ 141.83M | $ 18.22M |
| 2025 | $ 1.58M | $ -64.57M | $ -50.31M | $ 58.38M | $ 41.77M |
| 2024 | $ 0 | $ -43.64M | $ -30.36M | $ 54.80M | $ 13.15M |
| 2023 | $ 1.08M | $ -64.53M | $ -50.32M | $ 51.78M | $ 16.77M |
| 2022 | $ 5.59M | $ -65.23M | $ -58.92M | $ 2.49M | $ 66.35M |
| 2021 | $ 17.83M | $ -50.94M | $ -39.49M | $ 698.0K | $ 112.60M |
| 2020 | $ 0 | $ -63.65M | $ -64.63M | $ 941.0K | $ 143.12M |
| 2019 | $ 0 | $ -71.29M | $ -66.56M | $ 514.0K | $ 114.92M |
| 2018 | $ 0 | $ -30.62M | $ -27.80M | $ 0 | $ -55.21M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 7.79 |
| Liabilities / Eq | 8.97 |
| Current Ratio | 8.13 |

## Other views

- [Metrics](https://sponda.capital/en/MIST.md)
- [Charts](https://sponda.capital/en/MIST/charts.md)
- [Compare](https://sponda.capital/en/MIST/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.